|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.438
|
|
|
dna repair
|
GO:0006281 |
107 |
0.284
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.159
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.149
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.146
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.145
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.125
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.124
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.122
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.121
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.118
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.115
|
|
|
double strand break repair
|
GO:0006302 |
48 |
0.112
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.110
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.105
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.097
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.097
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.093
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.086
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.085
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.082
|
|
|
methylation
|
GO:0032259 |
134 |
0.081
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.078
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.078
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.070
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.069
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.069
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.066
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.066
|
|
|
histone modification
|
GO:0016570 |
159 |
0.066
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.066
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.064
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.062
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.061
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.060
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.059
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.059
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.057
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.057
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.056
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.055
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.054
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.054
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.053
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.053
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.051
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.049
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.049
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.049
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.046
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.046
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.045
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.045
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.044
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.044
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.043
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.043
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.043
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.041
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.041
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.040
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.040
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.040
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.040
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.040
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.039
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.039
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.039
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.039
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.039
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.039
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.039
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.038
|
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.037
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.036
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.036
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.036
|
|
|
double strand break repair via nonhomologous end joining
|
GO:0006303 |
10 |
0.036
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.036
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.036
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.035
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.035
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.035
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.034
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.034
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.034
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.033
|
|
|
protein processing
|
GO:0016485 |
163 |
0.032
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.032
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.032
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.032
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.032
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.032
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.032
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.031
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.031
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.031
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.031
|
|
|
dna damage checkpoint
|
GO:0000077 |
26 |
0.031
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.031
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.031
|
|
|
cellular response to radiation
|
GO:0071478 |
28 |
0.030
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.030
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.030
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.030
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.030
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.029
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.029
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.029
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.029
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.029
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.028
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.028
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.028
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.028
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.028
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.028
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.028
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.028
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.028
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.028
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.028
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.027
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.027
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.027
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.026
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.026
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.026
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.026
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.026
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.026
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.026
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.026
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.026
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.026
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.025
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.025
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.025
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.025
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.025
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.025
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.025
|
|
|
action potential
|
GO:0001508 |
78 |
0.025
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.025
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.025
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.025
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.024
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.024
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.023
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.023
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.023
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.023
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.023
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.023
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.023
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.023
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.023
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.022
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.022
|
|
|
double strand break repair via homologous recombination
|
GO:0000724 |
21 |
0.022
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.022
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.022
|
|
|
cellular response to ionizing radiation
|
GO:0071479 |
11 |
0.022
|
|
|
telomere maintenance
|
GO:0000723 |
19 |
0.022
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.022
|
|
|
cation transport
|
GO:0006812 |
399 |
0.022
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.022
|
|
|
somatic diversification of immune receptors
|
GO:0002200 |
53 |
0.022
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.022
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.022
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.022
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.022
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.022
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.022
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.022
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.022
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.021
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.021
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.021
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.021
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.021
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.021
|
|
|
dna replication
|
GO:0006260 |
52 |
0.021
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.021
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.021
|
|
|
negative regulation of cell division
|
GO:0051782 |
24 |
0.020
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.020
|
|
|
dna integrity checkpoint
|
GO:0031570 |
28 |
0.020
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.020
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.020
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.020
|
|
|
cell division
|
GO:0051301 |
120 |
0.020
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.020
|
|
|
somatic recombination of immunoglobulin gene segments
|
GO:0016447 |
42 |
0.020
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.020
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.020
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.019
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.019
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.019
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.019
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.019
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.019
|
|
|
somatic cell dna recombination
|
GO:0016444 |
51 |
0.019
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.019
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.019
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.019
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.018
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.018
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.018
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.018
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.018
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.018
|
|
|
positive regulation of intrinsic apoptotic signaling pathway
|
GO:2001244 |
25 |
0.018
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.018
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.018
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.018
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.018
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.018
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.018
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.018
|
|
|
chromosome organization involved in meiosis
|
GO:0070192 |
39 |
0.018
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.018
|
|
|
regionalization
|
GO:0003002 |
337 |
0.017
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.017
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.017
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.017
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.017
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.017
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.017
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.017
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.017
|
|
|
somatic diversification of immunoglobulins involved in immune response
|
GO:0002208 |
36 |
0.017
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.017
|
|
|
ossification
|
GO:0001503 |
216 |
0.017
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
30 |
0.017
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.017
|
|
|
cognition
|
GO:0050890 |
149 |
0.017
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.017
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.017
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.016
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.016
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.016
|
|
|
dna catabolic process
|
GO:0006308 |
19 |
0.016
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.016
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.016
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.016
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.016
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.016
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.016
|
|
|
bone development
|
GO:0060348 |
120 |
0.016
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.016
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.016
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.016
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.016
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.016
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.016
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.016
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.016
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.016
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.015
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.015
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.015
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.015
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.015
|
|
|
regulation of dna recombination
|
GO:0000018 |
34 |
0.015
|
|
|
reciprocal dna recombination
|
GO:0035825 |
16 |
0.015
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.015
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.015
|
|
|
response to x ray
|
GO:0010165 |
11 |
0.015
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.015
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.015
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.015
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.015
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.015
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.015
|
|
|
positive regulation of histone methylation
|
GO:0031062 |
16 |
0.015
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.015
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.015
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.015
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.015
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.015
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.015
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.015
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.015
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.015
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.015
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.015
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.014
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.014
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.014
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.014
|
|
|
cell cycle arrest
|
GO:0007050 |
37 |
0.014
|
|
|
tube formation
|
GO:0035148 |
140 |
0.014
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.014
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.014
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.014
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.014
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.014
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.014
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.014
|
|
|
somatic recombination of immunoglobulin genes involved in immune response
|
GO:0002204 |
36 |
0.014
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.014
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.014
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.014
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.014
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.014
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.014
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.014
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.014
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.014
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.014
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.014
|
|
|
heterochromatin organization
|
GO:0070828 |
4 |
0.014
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.014
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.014
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.014
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.014
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.014
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.014
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.014
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.014
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.014
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.014
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.013
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.013
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.013
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.013
|
|
|
limb development
|
GO:0060173 |
166 |
0.013
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.013
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.013
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.013
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.013
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.013
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.013
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.013
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
36 |
0.013
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.013
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.013
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.013
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.013
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.013
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.013
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.013
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.013
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.013
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
23 |
0.013
|
|
|
regulation of microtubule based process
|
GO:0032886 |
52 |
0.013
|
|
|
mitotic recombination
|
GO:0006312 |
3 |
0.013
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.013
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.013
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.013
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.012
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.012
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.012
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.012
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.012
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.012
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.012
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.012
|
|
|
somatic diversification of immunoglobulins
|
GO:0016445 |
43 |
0.012
|
|
|
recombinational repair
|
GO:0000725 |
21 |
0.012
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.012
|
|
|
appendage development
|
GO:0048736 |
166 |
0.012
|
|
|
nucleus organization
|
GO:0006997 |
45 |
0.012
|
|
|
ear development
|
GO:0043583 |
200 |
0.012
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.012
|
|
|
telomere maintenance in response to dna damage
|
GO:0043247 |
4 |
0.012
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.012
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.012
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.012
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.012
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.012
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.012
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.012
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.012
|
|
|
gonad development
|
GO:0008406 |
141 |
0.012
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.012
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.012
|
|
|
response to uv
|
GO:0009411 |
44 |
0.012
|
|
|
response to gamma radiation
|
GO:0010332 |
22 |
0.012
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.012
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.012
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
31 |
0.012
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.012
|
|
|
pallium development
|
GO:0021543 |
120 |
0.012
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.012
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.012
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.012
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.012
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.012
|
|
|
lung development
|
GO:0030324 |
164 |
0.012
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.012
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.012
|
|
|
b cell activation involved in immune response
|
GO:0002312 |
50 |
0.012
|
|
|
gland development
|
GO:0048732 |
330 |
0.012
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.012
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.011
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.011
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.011
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.011
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.011
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.011
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.011
|
|
|
isotype switching
|
GO:0045190 |
36 |
0.011
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.011
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.011
|
|
|
histone h3 k36 methylation
|
GO:0010452 |
6 |
0.011
|
|
|
amide transport
|
GO:0042886 |
138 |
0.011
|
|
|
synapsis
|
GO:0007129 |
34 |
0.011
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.011
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.011
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.011
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
35 |
0.011
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.011
|
|
|
dna dependent dna replication maintenance of fidelity
|
GO:0045005 |
3 |
0.011
|
|
|
segmentation
|
GO:0035282 |
93 |
0.011
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.011
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.011
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.011
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.011
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.011
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.011
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.011
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.011
|
|
|
response to drug
|
GO:0042493 |
75 |
0.011
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.011
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.011
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.011
|
|
|
signal transduction involved in dna damage checkpoint
|
GO:0072422 |
3 |
0.011
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.011
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.011
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.011
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.011
|
|
|
negative regulation of chromatin silencing
|
GO:0031936 |
1 |
0.011
|
|
|
nucleotide excision repair
|
GO:0006289 |
13 |
0.011
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.011
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.011
|
|
|
intra s dna damage checkpoint
|
GO:0031573 |
4 |
0.011
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.011
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.011
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.010
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.010
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.010
|
|
|
protection from non homologous end joining at telomere
|
GO:0031848 |
4 |
0.010
|
|
|
protein import
|
GO:0017038 |
101 |
0.010
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.010
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.010
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.010
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.010
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.010
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.010
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.010
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.010
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.010
|
|
|
negative regulation of protein catabolic process
|
GO:0042177 |
36 |
0.010
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.010
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.010
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.010
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.010
|
|
|
chromosome separation
|
GO:0051304 |
14 |
0.010
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.010
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.010
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.010
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.010
|
|